HeLa Cell Nuclear Extract Lysate

Cat# OCRA00101

Size : 200ug

Brand : Aviva Systems Biology

Request more information

Contact local distributor :


Phone : +1 850 650 7790

Datasheets/ManualsPrintable datasheet for OCRA00101
Product Info
Predicted Species ReactivityHuman
Product FormatLiquid (sterile filtered)
ConjugationUnconjugated
ApplicationWB
Additional InformationCell Line: HeLa - Human epidermoid carcinoma
Reconstitution and StorageStore HeLa Cell Nuclear Extract at -70°C or COLDER. For extended storage, aliquot Nuclear Extract to minimize freeze/thaw cycles. Expiration is three (3) months from date of opening.
Concentration1 mg/ml
Application InfoReady-to-use nuclear extracts are especially prepared as positive controls for separation by SDS-PAGE and subsequent western blot analysis. Nuclear extracts are supplied in denaturing buffer without dissociating agents. Heat nuclear extract to 95°C for 5 minutes and rapidly cool. If dissociating conditions are desired add reducing agent prior to heating. The recommended loading volume per lane is 10-30 ul depending on the size format of your gel.
PreparationThe cells were grown in Dulbecco’s medium supplemented with 10% fetal bovine serum. Cells were washed with PBS and then incubated on ice in modified RIPA buffer, containing 150 mM sodium chloride, 50 mM Tris HCl, pH 7.4, 1 mM EDTA, 1.0% NP-40, 0.5% sodium deoxycholic acid , 0.1% SDS and 0.01% (w/v) sodium azide to lyse the cells. Protein integrity was ensured using a cocktail of protease inhibitors with broad specificity for the inhibition of aspartic, cysteine, and serine proteases as well as aminopeptidases (0.1 mM AEBSF HCl, 0.08 µM Aprotinin, 5 uM Bestatin, 1.5 uM E-64, 2 uM Leupeptin Hemisulfate, 1 uM Pepstatin A). Phosphatase inhibitors 1 mM NaF and 1 mM Na3VO4 were also added. Cell debris was removed by centrifugation. Protein concentration was determined by a modified Lowry assay using a commercially available kit. Protein concentration was adjusted to 2 mg/ml and then an equal volume of 2X SDS-PAGE sample buffer was added.
Description of TargetReady-to-use nuclear extracts produced by Rockland Immunochemicals are derived from cell lines or tissues using highly refined extraction protocols to ensure exceptionally high quality, protein integrity and lot-to-lot reproducibility. All extracts are tested by SDS-PAGE using 4-20% gradient gels and immunoblot analysis using antibodies to key cell signaling components to confirm the presence of both high molecular weight and low molecular weight proteins.

You might also be interested by the following products:



Cat#
Description
Cond.
Price Bef. VAT